Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease | Zendy

Pierre Amarenco | Zendy; Larry B. Goldstein | Zendy; Henrik Sillesen | Zendy; Oscar Benavente | Zendy; Richard M. Zweifler | Zendy; Alfred Callahan | Zendy; Michael G. Hennerici | Zendy; Justin A. Zivin | Zendy; K.M.A. Welch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease

Author(s) -

Pierre Amarenco,

Larry B. Goldstein,

Henrik Sillesen,

Oscar Benavente,

Richard M. Zweifler,

Alfred Callahan,

Michael G. Hennerici,

Justin A. Zivin,

K.M.A. Welch

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.564781

Subject(s) - medicine , cardiology , stroke (engine) , atorvastatin , revascularization , coronary artery disease , vascular disease , myocardial infarction , mechanical engineering , engineering

Noncoronary forms of atherosclerosis (including transient ischemic attacks or stroke of carotid origin or >50% stenosis of the carotid artery) are associated with a 10-year vascular risk of >20% and are considered as a coronary heart disease (CHD) -risk equivalent from the standpoint of lipid management. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial included patients with stroke or transient ischemic attack and no known CHD regardless of the presence of carotid atherosclerosis. We evaluated the risk of developing clinically recognized CHD in SPARCL patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research